Santos Research Center, CORP

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease2 trials
• Crohn's disease1 trial
• High blood pressure1 trial
• Migraine1 trial
• Obesity1 trial
• Ulcerative colitis1 trial

Phase

• Phase 35 trials

Status

• Recruiting2 trials
• Active, not recruiting1 trial
• Completed1 trial
• Terminated1 trial

Lead sponsor

• Hoffmann-La Roche2 trials
• Boehringer Ingelheim1 trial
• Novo Nordisk A/S1 trial
• Pfizer1 trial

Running trials

• Recruiting

  A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

  NCT06819891· Phase 3· Hoffmann-La Roche· Source

• Active, not recruiting

  A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT06588855· Phase 3· Hoffmann-La Roche· Source

• Recruiting

  Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

  NCT05156398· Phase 3· Pfizer· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Crohn's disease1 recruiting
• Migraine1 recruiting

Closed trials

• Completed

  A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)

  NCT06077864· Phase 3· Boehringer Ingelheim· Source

• Terminated

  Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)

  NCT04968184· Phase 3· Novo Nordisk A/S· Source